T. Rowe Price Investment Management, Inc. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 438 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$45,045
+13.8%
283,282
+1.3%
0.03%
+18.5%
Q2 2023$39,576
+315.5%
279,768
+394.5%
0.03%
+285.7%
Q1 2023$9,526
+18.0%
56,581
+18.7%
0.01%
+16.7%
Q4 2022$8,072
-99.9%
47,671
+9.9%
0.01%0.0%
Q3 2022$8,113,00043,3580.01%
Other shareholders
REPLIGEN CORP shareholders Q4 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 812,225$215,110,0009.54%
Ally Bridge Group (NY) LLC 70,000$18,539,0006.48%
Miura Global Management 90,000$23,836,0004.04%
LRT Capital Management, LLC 16,710$4,425,0003.37%
AWM Investment Company, Inc. 100,000$26,484,0002.66%
Ranger Investment Management 175,179$46,394,0002.53%
Conestoga Capital Advisors, LLC 653,901$173,179,0002.25%
Spouting Rock Asset Management, LLC 10,679$2,828,0002.22%
Brown Capital Management 1,010,115$267,519,0002.21%
Yorktown Management & Research Co Inc 11,050$2,926,0001.98%
View complete list of REPLIGEN CORP shareholders